|Page (1) of 1 - 08/10/11||email article||print page|
J&J agrees to settle misdemeanor charge in sweeping federal probe of Risperdal marketing
WASHINGTON (AP) ' Johnson & Johnson says it has agreed to settle a single misdemeanor criminal charge related to a multi-year government investigation into the marketing of its psychiatric drug Risperdal.
The company said Monday in a regulatory filing that the agreement related to an allegation that the company promoted Risperdal for unapproved uses. Marketing drugs for unapproved uses is illegal.
The filing did not say what the New Jersey company would do as part of the settlement.
The Justice Department and the U.S. attorney's office in Philadelphia are pursuing other criminal and civil actions against the company.
Since 2004, J&J has received numerous subpoenas over Risperdal from federal and state prosecutors. J&J said Monday the government plans to join lawsuits filed by company whistleblowers who allege off-label marketing of Risperdal and a related drug Invega.